Advanced Prostate Cancer Sees Improved Survival with Radiopharmaceutical
The FDA recently granted approval for gallium Ga 68 gozetotide (Locametz), a radioactive tracer crucial for PET scans identifying tumors overproducing PSMA. To qualify for Lu177-PSMA-617 treatment, patients must first…